Journals in Pharmaceutical technology

4 results in All results

European Journal of Pharmaceutics and Biopharmaceutics

• ISSN: 0939-6411
• 5 Year impact factor: 4.8
• Impact factor: 4.4

Official Journal of the International Association for Pharmaceutical TechnologyThe European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.Topics covered include for example:Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)Aspects of manufacturing process designBiomedical aspects of drug product designStrategies and formulations for controlled drug transport across biological barriersPhysicochemical aspects of drug product developmentNovel excipients for drug product designDrug delivery and controlled release systems for systemic and local applicationsNanomaterials for therapeutic and diagnostic purposesAdvanced therapy medicinal productsMedical devices supporting a distinct pharmacological effect"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work: 1. The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance. 2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented. 3. The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.

Subscribe

International Journal of Pharmaceutics

• ISSN: 0378-5173
• 5 Year impact factor: 5.6
• Impact factor: 5.3

The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.

Subscribe

Journal of Clinical Epidemiology

• ISSN: 0895-4356
• 5 Year impact factor: 7.5
• Impact factor: 7.3

Metascience and innovative methods to improve population healthThe Journal of Clinical Epidemiology (JCE) aims to advance science that can improve health care decision-making and contribute to the evolving discipline of clinical epidemiology. The JCE publishes methods-focused articles across the spectrum of the research ecosystem, including primary research (qualitative, quantitative, and mixed); evidence syntheses; guidelines; and implementation science. The journal welcomes registered reports, protocols, and simulation studies that advance the journal’s aims. The JCE is committed to promoting equity, diversity, and inclusion across all its content, contributors, editorial board, and leadership. Priority is given to contributions from early and mid-career researchers and low- and middle-income countries.The journal publishes topics including:Meta-sciencePatient-oriented researchDevelopment, evaluation, and implementation of reporting guidelines Research integrity and cultureOpen scienceEmerging methodologies Developing and evaluating outcome measuresEducation and learning programs for clinical epidemiologistThe JCE does not accept the following submissions except in exceptional circumstances: Bibliometric studies and those on infodemiology, social media trends, and health informaticsPapers written primarily for a statistical audience Artificial intelligence and machine learning studies without critical evaluation of the method and transparent reportingMeta-research studies that demonstrate weaknesses or limitations in the evidence ecosystem but lack reflection on how these might be addressedEffectiveness studies, including Mendelian randomization studies and target trial emulations; systematic reviews; prevalence and incidence studies; prognostic or diagnostic research where the main focus is not on the methodsStudies limited to one country, jurisdiction, or clinical area with limited generalizability, such as: translating an outcome measure into a different language; a study focused on one clinical specialty; a Delphi/consensus-based study where all the authors are from one country; or a survey of participants from one setting or with a limited response rateStudies with a single author where it was more appropriate for a multi-disciplinary team to conduct the researchStudies that do not include patient partners as members of the research team in circumstances where that would be considered essentialAnimal studies Pharmacovigilance and pharmacoepidemiology studies

Subscribe

Journal of Drug Delivery Science and Technology

• ISSN: 1773-2247
• 5 Year impact factor: 4.7
• Impact factor: 4.5

The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. It is the Offical Journal of the Association de Pharmacie Galenique Industrielle (APGI), Associazione Docenti e Ricercatori Italiani di Tecnologie e Legislazione Farmaceutiche (ADRITELF), and Academy of Pharmaceutical Science and Technology, Japan (APSTJ).The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on: • Controlled release • Bioavailability and drug absorption • Nanomedicines • Gene delivery • Tissue engineering, etc.Hot topics, related to manufacturing processes and quality control, are also welcomed.

Subscribe